Sanofi (SNY) Treasury Shares (2009 - 2024)
Sanofi (SNY) posted Treasury Shares of -$325.2 million for Q2 2024, up 49.03% sequentially from -$638.0 million in Q4 2023, and up 17.72% YoY from -$276.3 million in Q3 2023.
Sanofi (SNY) Treasury Shares (2009 - 2024) Analysis & Trends
Sanofi (SNY) has 4 years of Treasury Shares data on file, last reported at -$839.4 million in Q2 2021.
- Quarterly Treasury Shares rose 17.72% year-over-year to -$325.2 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$325.2 million (up 17.72% YoY) and the FY2023 annual result came in at -$641.5 million, down 22.46% from the prior year.
- Treasury Shares climbed to -$325.2 million in Q2 2024 per SNY's latest filing, from -$638.0 million in the prior quarter.
- The five-year high for Treasury Shares was -$168.6 million in Q2 2021, with the low at -$980.1 million in Q4 2020.
- Average Treasury Shares over 5 years is -$470.3 million, with a median of -$397.6 million recorded in 2020.
- Year-over-year, Treasury Shares plunged 9738.02% in 2020 and surged 57.6% in 2021.
- Sanofi's Treasury Shares stood at -$980.1 million in 2020, then surged by 55.41% to -$437.0 million in 2021, then dropped by 16.03% to -$507.1 million in 2022, then slipped by 25.83% to -$638.0 million in 2023, then soared by 49.03% to -$325.2 million in 2024.
- Business Quant data shows SNY's Treasury Shares at -$839.4 million in Q2 2021, -$326.6 million in Q4 2015, and -$268.5 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 76.26 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 10.61 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.94 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -47.00 Mn |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -325.22 Mn |
| Jun 30, 2024 | -325.22 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Jun 30, 2023 | -395.28 Mn |
| Jun 30, 2023 | -395.28 Mn |
| Dec 31, 2022 | -507.06 Mn |
| Dec 31, 2022 | -507.06 Mn |
| Jun 30, 2022 | -384.14 Mn |
| Jun 30, 2022 | -384.14 Mn |
| Dec 31, 2021 | -437.00 Mn |
| Dec 31, 2021 | -437.00 Mn |
| Jun 30, 2021 | -839.38 Mn |
| Jun 30, 2021 | -839.38 Mn |
| Jun 30, 2021 | -168.60 Mn |
| Jun 30, 2021 | -168.60 Mn |
| Dec 31, 2020 | -980.06 Mn |
| Dec 31, 2020 | -980.06 Mn |
| Jun 30, 2020 | -397.63 Mn |
| Jun 30, 2020 | -397.63 Mn |